Blue water vaccines announces appointment of retired deloitte consulting senior managing director simon tarsh to board of directors

Cincinnati, aug. 22, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or “the company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the appointment of simon tarsh, seasoned financial consultant with experience in the life science industry, to its board of directors at bwv's annual meeting.
BWV Ratings Summary
BWV Quant Ranking